throbber
IJD_1452.fm Page 768 Wednesday, November 6, 2002 10:05 PM
`
`
`
`
`
`
`
`
`
`Blackwell Science, LtdOxford, UKIJDInternational Journal of Dermatology0011-9059Blackwell Science, 2002411000
`
`
`
`Report
`
`in acne rosacea

`Professor Mehmet Ali G(cid:159)rer, Associate Professor Arzu Erel, Professor Deniz Erba
`,
`g
`g
`Associate Professor Kayhan (cid:130)a
`lar, and Assistant Doctor (cid:130)i
`dem Atahan
`
`
`
`
`
`The seroprevalence of Helicobacter pylori and nitric oxide
`
`H. pylori and NO in acne rosaceaGürer et al.
`
`From the Departments of Dermatology,
`Physiology, and Clinical Microbiology, Faculty
`of Medicine, Gazi University, Besevler,
`Ankara, Turkey
`
`
`Correspondence
`
`Arzu Erel,
`MD
`Bilkent University
`Lojman No: 22/4
`06533 Bilkent, Ankara
`Turkey
`E-mail: aerel@med.gazi.edu.tr
`
`Abstract
`Background
`Acne rosacea is a dermatosis with unknown etiology. Some studies have
`
`
`reported a high prevalence of Helicobacter pylori infection in acne rosacea. Other studies have
`
`
`reported a decrease in the severity of the lesions of acne rosacea after eradication of H. pylori.
`
`H. pylori is a Gram-negative bacterium which colonizes the gastric mucosa and increases the
`synthesis of oxygen radicals, such as superoxide and proinflammatory cytokines. These cytokines
`have been demonstrated to stimulate the synthesis of the inflammatory species nitric oxide
`
`
`(NO). In this study, we examined the role of NO in the possible effect of H. pylori in acne rosacea.
`Methods
`Thirty-three acne rosacea patients were included in the study and the control group
`
`
`comprised 20 healthy individuals. The levels of immunoglobulin G antibodies against H. pylori
`in the serum samples were measured using the enzyme-linked immunoabsorbent assay
`method. Measurement of nitrate was performed using chemiluminescence in accordance with
`the method described by Braman and Hendrix (Braman RS, Hendrix SA. Nanogram nitrite and
`iii
`nitrate determination in environmental and biological materials by vanadium(
`) reduction with
`
`
`chemiluminescence detection. Anal Chem 1989; 61: 2715–2718). For statistical analysis, the
`
`
`
`t-test was used.
`Results
`The seropositivity of H. pylori in acne rosacea patients was found to be high; however,
`
`
`the serum nitrate levels were found to be normal.
`Conclusions
`The results of the study indicate that the inflammatory species NO, which has
`
`
`been hypothesized to be associated with H. pylori, has no role in the inflammatory mechanism
`of acne rosacea.
`
`Introduction
`
`Acne rosacea is an inflammatory skin disease that affects the
`central parts of the face. It is characterized clinically by
`papules and papulopustules, erythema, telangiectasia, and
`flushing episodes. The flushing episodes are seen generally in
`the initial stages of the disease and turn into permanent dark-
`red erythema in the later stages. The etiopathogenesis has not
`yet been clarified. Various factors are thought to affect the
`course of the disease, including the genetic predisposition of
`the individual, gastric hypochlorhydric dyspepsia, gastro-
`intestinal system infections, hypertension,
`Demodex folliculo-
`1—3
`, and psychogenic factors.
`
`
`Helicobacter pylori is the
`rum
`pathogenic bacterium responsible for the etiology of gastro-
`intestinal system infections from non-ulcer dyspepsia to the
`activation of peptic ulcer. Recent studies have shown that the
`prevalence of
`
`H. pylori infection is higher in acne rosacea
`4—6
`patients than in control groups.
` In another study,
`7
`s
`
`.
`Uta
` found that the seroprevalence of
`et al
`H. pylori
`
`768
`
`was the same as that of the control group, but a statistically
`significant decrease in the severity of the disease was reported
`with the treatment of seropositive acne rosacea patients with
`a combination of metronidazole, amoxicillin and bismuth
`compounds.
`
`H. pylori increases the synthesis of oxygen metabolites,
`such as superoxide and proinflammatory cytokines. These
`cytokines have also been shown to stimulate the synthesis of
`8—11
`the inflammatory species nitric oxide (NO).
`In this study, we investigated the role of NO in the possible
`effect of
`
`H. pylori in acne rosacea patients. The seropreval-
`
`H. pylori and the serum nitrate levels in a group of
`ence of
`acne rosacea patients were measured and compared with
`those of a control group consisting of healthy individuals.
`
`Materials and methods
`
`Thirty-seven acne rosacea patients (between the ages of 26 and
`67 years; 27 women and 10 men), who were seen at the Polyclinic
`
`
`
`International Journal of Dermatology 2002,
`, 768–770
`41
`
`
`
`© 2002 The International Society of Dermatology
`
`1
`
`Galderma Laboratories, Inc. Ex 2008
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IJD_1452.fm Page 769 Wednesday, November 6, 2002 10:05 PM
`
`
`
`Gürer et al.
`
`
`
`H. pylori and NO in acne rosacea
`
`Report
`
`769
`
`Table 1 Helicobacter pylori (HP) immunoglobulin G (IgG) results
`
`
`
`HP IgG (+)
`
`HP IgG (suspect)
`
`HP IgG (–)
`
`Total
`
`Patients
`Controls
`
`29
`9
`
`1
`3
`
`3
`8
`
`33
`20
`
`patient and control groups: both groups contained 75%
`women.
`H. pylori were positive in 29 (95.7%)
`
`IgG antibodies against
`of the acne rosacea patients, whereas in one (3.3%) patient
`they were found to be probably positive. Among individuals
`in the control group, nine (45%) were positive, whilst three
`(15%) were probably positive (Table 1). The seropositivity
`
`
`of H. pylori in the patient group was found to be statistically
`significantly higher than that of the control group (
`
`p < 0.005).
`The average nitrate level of the serum samples from the patients
` 9.85
`mol/L, whereas that of the control group
`was 49.27
`was 46.06
` 18.44
`mol/L. No statistically significant differ-
`ence was found between the nitrate levels of the two groups
`(
`
`p > 0.5).
`
`Discussion
`
`Acne rosacea is a dermatosis with unknown etiology. The dis-
`ease is associated with hypochlorhydria, gastritis and jejunal
`mucosal abnormalities, such as gastrointestinal system distur-
`
`H. pylori infection plays an etiologic role in the devel-
`bances.
`opment of chronic active gastritis, peptic ulcer disease, and
`gastric malignancy.
`
`H. pylori is a Gram-negative bacterium
`that colonizes the gastric mucosa. In various studies, it has
`been shown that inducible nitric oxide synthetase protein is
`expressed in the gastric mucosa of patients with active gast-
`ritis and
`
`H. pylori infection, and that large amounts of NO
`8—11
`are excreted from the gastric mucosa of these patients.
`NO is a colorless paramagnetic gas. It has radical charac-
`teristics due to the uncoupled single electron it carries in its
`outer orbital. In fluid media, it diffuses freely and passes
`through cell membranes easily. The half-life in tissues varies
`between 10 and 60 s. In water and plasma, it reacts with
`oxygen to form the nitrite, whilst in whole blood it reacts with
`hemoglobin to form the nitrate which is excreted in urine. The
`nitrites and nitrates have no biological activity. In biological
`systems, the measurement of NO is generally performed indir-
`ectly via its physiological activity. To determine the amount
`of NO in an organism, the serum or plasma nitrate and nitrite
`13,14
`levels, the end-products of NO, are used.
` NO is thought
`to play a role in vasodilatation, inflammation, and immuno-
`13,14
`modulation in the skin.
`Knowledge of the etiopathogenesis of acne rosacea is still
`very limited, and treatment is performed on a symptomatic
`basis. Studies on
`
`H. pylori in acne rosacea suggest that this
`
`or admitted to the ward of the Dermatology Department of Gazi
`University, Faculty of Medicine, between January 1998 and July
`1999, were included in the study. The patients had a disease
`duration varying between 4 months and 13 years. Twenty healthy
`individuals of similar gender and age distribution (20–69 years;
`15 women and five men) were selected as the control group.
`Acne rosacea can be clinically classified into four stages: stage
`I, episodic erythema and flushing attacks on the central areas of
`the face, the neck, and the V-shaped area of the chest (rosacea
`diathesis); stage II, persistent erythema and telangiectases; stage
`III, persistent erythema, telangiectases, and papules and pustules;
`stage IV, persistent erythema, telangiectases, papules, pustules,
`and nodules, and tissue hypertrophy (rhinophyma).
`The clinical diagnosis of acne rosacea was made according to
`the above stages. Patients in stages II, III, and IV were included in
`the study. All patients were also diagnosed histopathologically
`according to the clinical stage. The histopathologic diagnoses
`had been made previously in 13 patients, whereas the diagnoses
`were made during the study in 20 patients.
`Before blood samples were taken from the patients, it was made
`certain that they had not received topical or systemic drugs for acne
`rosacea for at least 1 week. This period was determined from the
`half-lives of the drugs used in the treatment of acne rosacea to avoid
`the influence of the possible anti-inflammatory effects of these drugs.
`Four blood samples (three women and one man) could not be
`analyzed because of hemolysis. From the blood samples of both the
`3
`patient and control groups, 5 cm
` portions were drawn into test tubes
`containing gel and centrifuged. These samples were stored
`at
`20
`C until analysis.
`The amount of total nitrate in the test samples was determined
`by a modification of the procedure described by Braman and
`12
`Hendrix
` using the purge system of a Sievers Instruments Model
`280A Nitric Oxide Analyzer. A standard curve was constructed
`using various concentrations of NO
`(10–100
`). The nitrate
`M
`levels of the samples were calculated using the standard curve.
`Results were expressed as the mean
` standard deviation (SD).
`
`The level of immunoglobulin G (IgG) antibodies against H.
`
`pylori in the serum samples was measured using the enzyme-linked
`immunoabsorbent assay (ELISA) method (International Immuno-
`Diagnostics, USA). The antibody titer of each serum sample was
`determined using the calibration curve. A sample was considered
`to be positive if the IgG value was equal to or greater than 100 EU/
`mL. If the value was between 91 and 99 EU/mL, it was considered
`to be equivocal. If the value was lower than 90 EU/mL, it was
`considered to be negative.
`
`3–
`
`Results
`
`Thirty-three acne rosacea patients were compared with the
`20 healthy individuals of the control group in terms of the
`average age (48.21 and 46.35 years, respectively) and no
`statistically significant difference was found between the groups.
`There was also no difference in terms of gender between the
`
`
`
`© 2002 The International Society of Dermatology
`
`
`
`International Journal of Dermatology 2002,
`, 768–770
`41
`
`2
`
`Galderma Laboratories, Inc. Ex 2008
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778
`
`-
`(cid:176)
`m
`–
`–
`m
`–
`m
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IJD_1452.fm Page 770 Wednesday, November 6, 2002 10:05 PM
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`770
`
`Report
`
`
`
`H. pylori and NO in acne rosacea
`
`
`
`Gürer et al.
`
`
`
` D. Nitric oxide in health. Gazi Med J 1998; 9:
`
`
`
`seroprevalence in patients with acne rosacea. (Abstract).
`
`
`J Eur Acad Dermatol Venereol 1995; 5 (Suppl. 1): 151.
`
`6 Jones MP, Knable AL, White MJ, Durning SJ. Helicobacter
`pylori in rosacea: lack of an association. (letter).
`Arch
`
`
` 1998; 134: 511.
`Dermatol
`$
`$
` S, (cid:133)zbakır (cid:133), Turasan A, Uta
` C. Helicobacter
`7 Uta
`pylori eradication treatment reduces the severity of rosacea.
`
`
`J Am Acad Dermatol 1999; 40: 3.
`
`et al. Helicobacter pylori
`
`8 Tsuji S, Kawano S, Tsujii M,
`extract stimulates inflammatory nitric oxide production.
`
`
`Cancer Lett 1996; 108: 195—200.
`
`9 Franco L, Talamini G, Carra G, Doria D. Expression of
`COX-1, COX-2, and inducible nitric oxide synthase
`protein in human gastric antrum with Helicobacter pylori
`
`
`Prostaglandins Other Lipid Med 1999; 58:
`
`infection.
`9—17.
`et al. Inducible nitric
`
`10 Mannick EE, Bravo E, Zarama G,
`oxide synthase, nitrotyrosine, and apoptosis in Helicobacter
`pylori gastritis: effect of antibiotics and antioxidants.
`Cancer
`
`
` 1996; 56: 3238—3243.
`Res
`11 Shapiro KB & Hotchkiss JP. Induction of nitric oxide
`synthesis in murine macrophages by Helicobacter pylori.
`
`
`Cancer Lett 1996; 102: 49—56.
`
`12 Braman RS & Hendrix SA. Nanogram nitrite and nitrate
`determination in environmental and biological materials by
`
`iii) reduction with chemiluminescence detection.
`vanadium(
`
`
`Anal Chem 1989; 61: 2715—2718.
`
`$
`
`
`13 Erba
`1—36.
`
`
`14 Kiechle F,
`567—573.
`
`pathogen may be an aggravating factor rather than an
`1—3
`etiologic cause.
`In this study, we investigated the role of NO in the possible
`effect of
` in patients with acne rosacea. The sero-
`H. pylori
`positivity of
`
`H. pylori in acne rosacea patients was found to
`be significantly high, whereas the serum nitrate levels of the
`patients were normal. Based on the results of the study, we
`conclude that the inflammatory species NO, which has been
`
`H. pylori, has no role in
`hypothesized to be associated with
`the inflammatory mechanism of acne rosacea.
`
`Acknowledgments
`
`This study was supported by the Gazi University Research
`Fund.
`
`References
`
`1 Plewig G, Jansen T. Rosacea. In: Freedberg IM,
`
`
`et al., eds. Dermatology in General
`Eisen AZ, Wolff K,
`, 5th edn. Philadelphia: McGraw-Hill Company,
`Medicine
`1999: 785—794.
`2 Wilkin JK. Rosacea pathophysiology and treatment.
`
`
`Arch Dermatol 1994; 130: 359—362.
`
`Retinoids 1998; 14: 117.
`
`
`
`3 Griffiths WAD. Rosacea.
`4 Rebora A, Drago F, Picciotto A. Helicobacter pylori in
`
`
`Am J Gastroenterol 1994; 89:
`
`patients with rosacea.
`1603—1604.
`$
`j
` M,
`
`5 Erel A, (cid:133)zta
`
`
`
`lter N, et al. Helicobacter pylori
`
`
`
`Malinski T. Nitric oxide. Clin Chem 1993; 100:
`
`
`
`
`
`
`
`International Journal of Dermatology 2002,
`, 768–770
`41
`
`
`
`© 2002 The International Society of Dermatology
`
`3
`
`Galderma Laboratories, Inc. Ex 2008
`Dr. Reddy's Labs v. Galderma Labs., Inc.
`IPR2015-01778

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket